Comparison of two competing pharmacometric models is undertaken using graphic representations to elucidate their similarities and differences. The effect compartment model and the indirect response model are simulated and compared for a range of parameters to determine to what extent their dynamic characteristics can be matched. Visual tools such as hysteresis curves are used to examine model dynamics in a variety of ways. Differentiation is facilitated to the extent that competing models have distinctly defined dynamics. For the models studied here, the degree of difference depends on the region in parameter space which in turn relates to clinical response.
INTRODUCTION
Clinical trials are used to establish the safety and efficacy of drugs. Dose levels and frequency of medication are set for testing both safety and efficacy. Data from clinical trials are then studied to characterize the response to medication levels in terms of successful endpoints and adverse events. Efficacy and adverse events are both affected by the amount of drug the person is exposed to. Trials serve to estimate optimal dosages. Optimality varies by individual depending on drug concentration and drug sensitivity.
The same dosage leads to different concentrations in individuals due to many causes, such as variability in rates of metabolism and drug clearance.
Pharmacokinetics, therefore, focuses on determining blood plasma concentrations of drugs. Pharmacokinetics deals with the response to the presence of drugs. A central idea is the postulation of a direct link between concentration and response. This framework led to progress in many cases by guiding the adjustment of dosages to get desired concentration levels.
Taking the concentration-response viewpoint literally failed to explain cases where greater effects occurred after concentrations were falling. This paper deals with two classes of models formulated to account for this and the similarities and differences in model predictions.
BACKGROUND
Compartmental analysis assumes that the distribution of drugs in the body can be modeled by a discrete number of well stirred compartments.
In the simplest case one compartment can satisfactorily fit the plasma concentration data. We deal with such a case. Effects considered are those which lag plasma concentration. We do not consider lag cases where the cause for delay of effect is the time needed for a drug in plasma to equilibrate with a target organ as such cases are accounted for by multicompartmental models. When delayed effects are graphed versus plasma concentration, the data form loops with two values associated with a single concentration (Roland and Tozer 1995) . An example is shown in Figure 3b . Such graphs are referred to as hysteresis curves and are known in other disciplines as phase space diagrams.
A way out of the multiple value dilemma regarding concentration and effect is known as the effect compartment model (Segre 1968, Verotta and Sheiner 1991) . This approach postulates that the drug acts from a hypothetical effect compartment which uses an unobservable amount of drug. Concentration in the effect compartment, for cases considered in this paper, lags the concentration in the central blood compartment. By adjusting the elimination coefficient of the effect compartment (Keo), it is possible to "collapse the hysteresis loop" so that effect versus effect compartment concentration is a univalued function. Essentially the effect compartment concentration profile is shifted so that its time course coincides with the course of the effect. In our study of data for nonsteroidal anti-inflammatory drugs (NSAIDS) given for pain and fever, we have used this effect compartment methodology to account for the data. However, delay mechanisms in such cases might arise from the existence of a classical feedback loop controlling the level of fever or pain (Katzper and Holford 1990) . In the case of fever, the effect compartment approach is now not considered reasonable on physiological grounds (Roland and Tozer 1995) .
Later observations
showed that open control loop mechanisms are sufficient to model many cases of interest including pain and fever (Dayneka et al, 1993 , Katzper 1992 Figure 1 . In subsequent sections these models will be explained further. Then by using identical pharmacokinetics, the pharmacodynamics of the models will be compared in a variety of physiological ranges. If one is to subscribe to the notion that the effect is solely and instantaneously related to the drug concentration, then a possible explanation is in terms of an effect compartment which does not affect the blood level concentration noticeably. Specifically we will look at this model in the context of an intravenous infusion which is terminated after a time. Our models are formulated using STELLA (Bogen 1989) . The visual programming approach simplifies the formulation of complex models (Katzper 1992) The plasma concentration of drug rises during the infusion and subsequently falls as shown for a sample case in Figure 3a together with the associated effect.
Plotting effect versus plasma concentration, we obtain the hysteresis curve shown in Figure 3b . critique was the observation of the dose dependency of the parameters to achieve the best fit. This is biologically implausible. Verotta turned the approach around (Verotta 1995) . He showed, using simulation and experimental data, good fits with the effect compartment model in cases where the dynamic response model gave inferior results.
None of this dose respone related work will be replicated here. Our conclusion from this dispute is that unbiased guidance is needed to assist in determining the appropriate model. Our first case is set for a large time klg between concentration and effect. As explained, this is achieved by setting KD and Keo low. The relationship between concentration and effect is set to be highly nonlinear. This An interesting feature is that the dynamic model achieves its maximum fairly late during the decline of the concentration. Another feature, which is good from a medical perspective is the maintenance of the effect after infusion stops for a steep drop in concentration, Figure 7 , a plot of the effects predicted by one model versus the other, would give a straight diagonal line for identical models. As such, the deviations from fourty five degrees show the deviations of the models from each The second case was set to retain a large lag by keeping KD and Keo low but was set to approximate linearity in the dynamic model link by setting C50 high and in the effect link by setting EC50 high. One might think of the modeling process as the application of transformation operators on the input variables. An examination of the structure of the two models shows that they can be looked upon as two similar transformations taken in different sequence. The operations are non-commutative. However, for certain parametric combinations they approach commutativity.
In plain English, the models approach each other in terms of their results.
For this case, we describe the graphic results. There is a near superposition of model results in a direct comparison versus time. The size of the effect is a little less than half of that in the first case. The hysteresis curve still has a large lag, but the linearity of the underlying relationship causes a slower rise in effect and a more rapid decline. This is the case for both models which are nearly superimposed. The direct comparison of the effects (not shown) maintains the reclining figure eight, but in a squashed form approximating a diagonal line. The models difference curve (not shown) retains lead lag variations because the plot scale is an order of magnitude smaller than the prior case. This demonstrates that systematic variation between the models is maintained. An improved match between the two models can not be expected from further parameter variation. This is acceptable for practical purposes as there is no known outcome which would be affected. The third case is that of a small lag between blood concentration and effect. This is achieved by setting KD and Keo high. In addition the effect is in the linear relationship range for linking effect to concentration.
Linearity is achieved by setting C50 and EC50 to high values.
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In this case, not only do the time curves of the models coincide but the effect curve closely approximates the shape of the infusion plasma concentration curve. At the selected parameter settings, both models still retain a lag as seen by the reduced enclosed area in Figure 9 . The final case in our illustrative set is also chosen to retain a small lag between blood concentration and effect.
As before, the lag is achieved by keeping K]> and Keo high. However, here the nonlinear range for linking effect to concentration has been chcsen by setting C50 and EC50 lowwith respect to the concentration level achieved by the dosing regimen. The two parameters of the respective models can be adjusted so that the model results nearly coincide.
The hysteresis curve, Figure 10 , clearly shows the nonlinearity of the effect. The comparative computer graphics of the hysteresis curves (not shown here)
demonstrate the retention of the lead-lag pattern, but with only a very small gap between the curves. The collapse of the area of the hysteresis curve in the limit will lead to a logistic like curve.
DISCUSSION
All of these studies have been made without the random variability whiclh accompanies experimental data. A reason for this investigation was to determine whether the structural form of the model formulations was sufficient to create dynamic results which could not be made to coincide. Then it might be possible to clifferentiate between models based solely on the observed data even when noise N present. Furthermore, different graphical representations were used to enhance the difference signal. The rather unexpected result, as has been shown, is that for the present dosing regimen, differences are discernible only in the parameter range giving strong model effects of large lag and nonlinearity. The limits of differentiation are dependent on the noise level. Combining information regarding the intrinsic response with results from multiple dose level fitting will enhance model discrimination.
Real data also do not allow for the density of observations or the length of observation used here. It must be kept in mind that we have purposely dealt with an idealized case. In our studies of pain the data are more complex with contributions from placebo effects and gastric transit variability forcing us to construct more complex models (Harter and Katzper 1994) .
In matching complex data our guidance has come from having multiple data sources and from physiological considerations Katzper 1993, Harter and Katzper 1995) .
Phase relationships between the models require a long interval of data for the changing relationships to aid in discerning which model is in better agreement with the data. Short interval fits will not do the job.
This model study with its limited focus only provides general guidance for the real problems we are addressing. Additional sources of information must be sought in deciding which model is more appropriate.
To assist in interpreting the time course and hysteresis loops of the data we have seen, a series of simulation experiments have been carried out for competing models.
A selected summary of these runs has been presented. On the other hand, with only limited noisy data, one might be misled by the model fit obtained. When both models are approximately equivalent in their ability to fit available data one may ask why worry about which model is used? Because the model is our conceptual framework for understanding the subject matter. A model corresponding to the underlying reality has the possibility of forming the basis for further fruitful investigation and elaboration.
In the converse situation, we have a well fitted dead end.
